Factors shaping the composition of the cutaneous microbiota

British Journal of Dermatology

Volumn 176, Issue 2, 2017, Pages 344-351

  Szabo K ^a   Erdei, L ^a   Bolla, B Sz ^a   Tax, G ^a   Biro T ^b   Kemeny L ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE VULGARIS; BACTERIAL COLONIZATION; DERMATITIS; DYSBIOSIS; ENVIRONMENTAL FACTOR; HOST PATHOGEN INTERACTION; HUMAN; LIFESTYLE MODIFICATION; MICROBIAL COMMUNITY; NONHUMAN; ORGANISMAL INTERACTION; PATHOGENESIS; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; REVIEW; SKIN CELL; SKIN FLORA; SOCIOECONOMICS; BACTERIAL SKIN DISEASE; DEMOGRAPHY; ENVIRONMENT; GRAM POSITIVE INFECTION; LIFESTYLE; MICROBIOLOGY; MICROFLORA; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN;

ACNE VULGARIS; ENVIRONMENT; GRAM-POSITIVE BACTERIAL INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; LIFE STYLE; MICROBIOTA; PROPIONIBACTERIUM ACNES; RESIDENCE CHARACTERISTICS; SKIN; SKIN DISEASES, BACTERIAL; SOCIOECONOMIC FACTORS;

EID: 85010777987     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14967     Document Type: Review

References (84)

1. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977; 31:107–33.
2. Ottman N, Smidt H, de Vos WM et al. The function of our microbiota: who is out there and what do they do? Front Cell Infect Microbiol 2012; 2:104.
3. Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet 2012; 13:260–70.
4. Shulman ST, Friedmann HC, Sims RH. Theodor Escherich: the first pediatric infectious diseases physician? Clin Infect Dis 2007; 45:1025–9.
5. Mackowiak PA. The normal microbial flora. N Engl J Med 1982; 307:83–93.
6. Human Microbiome Project Consortium. A framework for human microbiome research. Nature 2012; 486:215–21.
7. Ley RE, Lozupone CA, Hamady M et al. Worlds within worlds: evolution of the vertebrate gut microbiota. Nat Rev Microbiol 2008; 6:776–88.
8. Lee YK, Mazmanian SK. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 2010; 330:1768–73.
9. Aagaard K, Ma J, Antony KM et al. The placenta harbors a unique microbiome. Sci Transl Med 2014; 6:237.
10. Marsland BJ, Salami O. Microbiome influences on allergy in mice and humans. Curr Opin Immunol 2015; 36:94–100.
11. Dickson RP, Huffnagle GB. The lung microbiome: new principles for respiratory bacteriology in health and disease. PLoS Pathog 2015; 11:e1004923.
12. Gallo RL, Nakatsuji T. Microbial symbiosis with the innate immune defense system of the skin. J Invest Dermatol 2011; 131:1974–80.
13. Littman DR, Pamer EG. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 2011; 10:311–23.
14. Kranich J, Maslowski KM, Mackay CR. Commensal flora and the regulation of inflammatory and autoimmune responses. Semin Immunol 2011; 23:139–45.
15. Grice EA, Kong HH, Conlan S et al. Topographical and temporal diversity of the human skin microbiome. Science 2009; 324:1190–2.
16. Jahns AC, Alexeyev OA. Three dimensional distribution of Propionibacterium acnes biofilms in human skin. Exp Dermatol 2014; 23:687–9.
17. Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol 2011; 9:244–53.
18. Zeeuwen PL, Boekhorst J, van den Bogaard EH et al. Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol 2012; 13:R101.
19. Penders J, Thijs C, Vink C et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006; 118:511–21.
20. Dominguez-Bello MG, Costello EK, Contreras M et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010; 107:11971–5.
21. Azad MB, Konya T, Maughan H et al. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ 2013; 185:385–94.
22. Coughlin CC, Taieb A. Evolving concepts of neonatal skin. Pediatr Dermatol 2014; 31(Suppl. 1):5–8.
23. Hardin G. The competitive exclusion principle. Science 1960; 131:1292–7.
24. Adlerberth I, Lindberg E, Aberg N et al. Reduced enterobacterial and increased staphylococcal colonization of the infantile bowel: an effect of hygienic lifestyle? Pediatr Res 2006; 59:96–101.
25. Malago JJ. Contribution of microbiota to the intestinal physicochemical barrier. Benef Microbes 2015; 6:295–311.
26. Fujimura S, Nakamura T. Purification and properties of a bacteriocin-like substance (acnecin) of oral Propionibacterium acnes. Antimicrob Agents Chemother 1978; 14:893–8.
27. Hassan M, Kjos M, Nes IF et al. Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance. J Appl Microbiol 2012; 113:723–36.
28. Christensen GJ, Bruggemann H. Bacterial skin commensals and their role as host guardians. Benef Microbes 2014; 5:201–15.
29. Pochi PE, Strauss JS, Downing DT. Age-related changes in sebaceous gland activity. J Invest Dermatol 1979; 73:108–11.
30. Zouboulis CC, Boschnakow A. Chronological ageing and photoageing of the human sebaceous gland. Clin Exp Dermatol 2001; 26:600–7.
31. Hoath SB, Pickens WL, Visscher MO. The biology of vernix caseosa. Int J Cosmet Sci 2006; 28:319–33.
32. Rissmann R, Groenink HW, Weerheim AM et al. New insights into ultrastructure, lipid composition and organization of vernix caseosa. J Invest Dermatol 2006; 126:1823–33.
33. Hoeger PH, Schreiner V, Klaassen IA et al. Epidermal barrier lipids in human vernix caseosa: corresponding ceramide pattern in vernix and fetal skin. Br J Dermatol 2002; 146:194–201.
34. Drake DR, Brogden KA, Dawson DV et al. Thematic review series: skin lipids. Antimicrobial lipids at the skin surface. J Lipid Res 2008; 49:4–11.
35. Singh G, Archana G. Unraveling the mystery of vernix caseosa. Indian J Dermatol 2008; 53:54–60.
36. Visscher MO, Narendran V, Pickens WL et al. Vernix caseosa in neonatal adaptation. J Perinatol 2005; 25:440–6.
37. Tollin M, Jagerbrink T, Haraldsson A et al. Proteome analysis of vernix caseosa. Pediatr Res 2006; 60:430–4.
38. Bendtsen KM, Fisker L, Hansen AK et al. The influence of the young microbiome on inflammatory diseases-Lessons from animal studies. Birth Defects Res C Embryo Today 2015; 105:278–95.
39. Oh J, Conlan S, Polley EC et al. Shifts in human skin and nares microbiota of healthy children and adults. Genome Med 2012; 4:77.
40. Trivedi B. Microbiome: the surface brigade. Nature 2012; 492:S60–1.
41. Shu M, Wang Y, Yu J et al. Fermentation of Propionibacterium acnes, a commensal bacterium in the human skin microbiome, as skin probiotics against methicillin-resistant Staphylococcus aureus. PLoS ONE 2013; 8:e55380.
42. Tan J, McKenzie C, Potamitis M et al. The role of short-chain fatty acids in health and disease. Adv Immunol 2014; 121:91–119.
43. Wang Y, Dai A, Huang S et al. Propionic acid and its esterified derivative suppress the growth of methicillin-resistant Staphylococcus aureus USA300. Benef Microbes 2014; 5:161–8.
44. Elias PM. The skin barrier as an innate immune element. Semin Immunopathol 2007; 29:3–14.
45. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 2009; 7:887–94.
46. Fierer N, Hamady M, Lauber CL et al. The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proc Natl Acad Sci U S A 2008; 105:17994–9.
47. Mikova R, Vrkoslav V, Hanus R et al. Newborn boys and girls differ in the lipid composition of vernix caseosa. PLoS ONE 2014; 9:e99173.
48. Staudinger T, Pipal A, Redl B. Molecular analysis of the prevalent microbiota of human male and female forehead skin compared to forearm skin and the influence of make-up. J Appl Microbiol 2011; 110:1381–9.
49. Man MQ, Xin SJ, Song SP et al. Variation of skin surface pH, sebum content and stratum corneum hydration with age and gender in a large Chinese population. Skin Pharmacol Physiol 2009; 22:190–9.
50. Zeeuwen PL, Kleerebezem M, Timmerman HM et al. Microbiome and skin diseases. Curr Opin Allergy Clin Immunol 2013; 13:514–20.
51. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299:1259–60.
52. Cookson WO, Moffatt MF. Asthma: an epidemic in the absence of infection? Science 1997; 275:41–2.
53. Heederik D, von Mutius E. Does diversity of environmental microbial exposure matter for the occurrence of allergy and asthma? J Allergy Clin Immunol 2012; 130:44–50.
54. Warinner C, Rodrigues JF, Vyas R et al. Pathogens and host immunity in the ancient human oral cavity. Nat Genet 2014; 46:336–44.
55. Adler CJ, Dobney K, Weyrich LS et al. Sequencing ancient calcified dental plaque shows changes in oral microbiota with dietary shifts of the Neolithic and Industrial revolutions. Nat Genet 2013; 45:450–5.
56. Clemente JC, Pehrsson EC, Blaser MJ et al. The microbiome of uncontacted Amerindians. Sci Adv 2015; 1:pii:e1500183.
57. Yatsunenko T, Rey FE, Manary MJ et al. Human gut microbiome viewed across age and geography. Nature 2012; 486:222–7.
58. Blaser MJ, Dominguez-Bello MG, Contreras M et al. Distinct cutaneous bacterial assemblages in a sampling of South American Amerindians and US residents. ISME J 2013; 7:85–95.
59. Blaser MJ. Who are we? Indigenous microbes and the ecology of human diseases. EMBO Rep 2006; 7:956–60.
60. Blaser MJ. Disappearing microbiota: helicobacter pylori protection against esophageal adenocarcinoma. Cancer Prev Res (Phila) 2008; 1:308–11.
61. Peterson J, Garges S, Giovanni M et al. The NIH Human Microbiome Project. Genome Res 2009; 19:2317–23.
62. Leung MH, Wilkins D, Lee PK. Insights into the pan-microbiome: skin microbial communities of Chinese individuals differ from other racial groups. Sci Rep 2015; 5:11845.
63. Lai Y, Di NA, Nakatsuji T et al. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med 2009; 15:1377–82.
64. Bojar RA, Holland KT. Acne and Propionibacterium acnes. Clin Dermatol 2004; 22:375–9.
65. Dessinioti C, Katsambas AD. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies. Clin Dermatol 2010; 28:2–7.
66. Shaheen B, Gonzalez M. A microbial aetiology of acne: what is the evidence? Br J Dermatol 2011; 165:474–85.
67. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet 2012; 379:361–72.
68. Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol 2009; 129:2136–41.
69. Saitta P, Keehan P, Yousif J et al. An update on the presence of psychiatric comorbidities in acne patients, part 1: overview of prevalence. Cutis 2011; 88:33–40.
70. Steiner PE. Necropsies on Okinawans; anatomic and pathologic observations. Arch Pathol (Chic) 1946; 42:359–80.
71. Findlay GH. The age incidence of common skin diseases in the white population of the Transvaal. Br J Dermatol 1967; 79:538–42.
72. Park RG. The age distribution of common skin disorders in the Bantu of Pretoria, Transvaal. Br J Dermatol 1968; 80:758–61.
73. Freyre EA, Rebaza RM, Sami DA et al. The prevalence of facial acne in Peruvian adolescents and its relation to their ethnicity. J Adolesc Health 1998; 22:480–4.
74. Cordain L, Lindeberg S, Hurtado M et al. Acne vulgaris: a disease of Western civilization. Arch Dermatol 2002; 138:1584–90.
75. Szabo K, Kemeny L. Studying the genetic predisposing factors in the pathogenesis of acne vulgaris. Hum Immunol 2011; 72:766–73.
76. Cove JH, Cunliffe WJ, Holland KT. Acne vulgaris: is the bacterial population size significant? Br J Dermatol 1980; 102:277–80.
77. Leyden JJ, McGinley KJ, Vowels B. Propionibacterium acnes colonization in acne and nonacne. Dermatology 1998; 196:55–8.
78. Shaheen B, Gonzalez M. Acne sans P. acnes. J Eur Acad Dermatol Venereol 2013; 27:1–10.
79. Jahns AC, Lundskog B, Ganceviciene R et al. An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study. Br J Dermatol 2012; 167:50–8.
80. Coenye T, Peeters E, Nelis HJ. Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors. Res Microbiol 2007; 158:386–92.
81. Fitz-Gibbon S, Tomida S, Chiu BH et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol 2013; 133:2152–60.
82. Kelly CR, Kahn S, Kashyap P et al. Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology 2015; 149:223–37.
83. Saez-Lara MJ, Robles-Sanchez C, Ruiz-Ojeda FJ et al. Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a review of human clinical trials. Int J Mol Sci 2016; 17:E928.
84. Dominguez-Bello MG, De Jesus-Laboy KM, Shen N et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med 2016; 22:250–3.